Confident LIMS

est. 2Y upside i

Laboratory Information Management System (LIMS) serving…

Rank

#2264

Sector

LIMS Software, SaaS

Est. Liquidity

~3Y

Data Quality

Data: Low

Due to extensive missing financial data (revenue, valuation, growth, funding), a quantitative equity upside analysis is not feasible.

Last updated: July 19, 2026

Bull (10%)0%

Optimistic scenario relies on expanded market share in new verticals and IPO window, but no financial data to quantify.

Base (55%)0%

Base case assumes moderate growth in core cannabis testing market, but lack of revenue and valuation data prevents meaningful projection.

Bear (35%)0%

Bear case sees incumbent competition eroding market share and tight funding environment, but without financials, impact cannot be quantified.

Est. time to liquidity~3.0 years

Preference Stack Risk

moderate

Funding Intensity

No funding data available; preference stack risk cannot be assessed but is presumed moderate given typical early-stage capitalization.

Dilution Risk

high

Without funding history, the likelihood of future dilutive raises is unknown, but given early stage and expansion plans, dilution is probable.

Secondary Liquidity

none

No secondary market activity reported; liquidity for employee equity is likely limited to a future exit.

Questions to Ask at the Interview

Strategic questions based on Confident LIMS's data — designed to show you've done your homework.

1
“What are the company's current annual recurring revenue (ARR) and growth rate?”
2
“How does the company plan to defend against large incumbents when expanding outside cannabis?”
3
“What is the expected timeline for an IPO or major liquidity event, and what valuation is implied?”

Our model estimates 0% upside. What do you think?

Anonymous. Do not share material non-public information.

Comments are reviewed before they appear publicly.

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.